CARREGA, Paolo
 Distribuzione geografica
Continente #
EU - Europa 2.413
NA - Nord America 1.851
AS - Asia 1.221
SA - Sud America 371
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.905
Nazione #
US - Stati Uniti d'America 1.814
RU - Federazione Russa 1.230
SG - Singapore 468
CN - Cina 410
BR - Brasile 325
IT - Italia 261
IE - Irlanda 236
SE - Svezia 223
PL - Polonia 165
HK - Hong Kong 122
VN - Vietnam 92
FR - Francia 68
DE - Germania 54
GB - Regno Unito 39
UA - Ucraina 31
IN - India 29
FI - Finlandia 27
BE - Belgio 21
AR - Argentina 19
ZA - Sudafrica 17
AT - Austria 16
CA - Canada 14
ID - Indonesia 14
MX - Messico 13
BD - Bangladesh 11
TR - Turchia 11
IQ - Iraq 9
MA - Marocco 9
NL - Olanda 8
UZ - Uzbekistan 8
EC - Ecuador 7
ES - Italia 7
JP - Giappone 6
PH - Filippine 6
PK - Pakistan 6
CL - Cile 5
CO - Colombia 5
CZ - Repubblica Ceca 5
TN - Tunisia 5
EG - Egitto 4
MY - Malesia 4
PY - Paraguay 4
AL - Albania 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
JM - Giamaica 3
MD - Moldavia 3
RO - Romania 3
VE - Venezuela 3
DZ - Algeria 2
GR - Grecia 2
IR - Iran 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BT - Bhutan 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
TG - Togo 1
TH - Thailandia 1
TW - Taiwan 1
Totale 5.905
Città #
Ashburn 347
Moscow 329
Singapore 254
Dublin 235
Chandler 188
Warsaw 165
Dallas 162
Nyköping 153
Messina 145
Beijing 126
Hong Kong 121
San Jose 91
The Dalles 83
Jacksonville 74
Ann Arbor 65
Los Angeles 46
Princeton 37
Lauterbourg 34
Medford 34
Ho Chi Minh City 32
Des Moines 27
Dearborn 26
Cambridge 25
Guangzhou 23
São Paulo 22
Brussels 21
Tianjin 21
Boardman 20
Buffalo 19
New York 18
Munich 16
Redondo Beach 15
Dong Ket 14
Orem 14
Santa Clara 14
Shanghai 14
Wilmington 14
Woodbridge 14
Council Bluffs 13
Shenyang 13
Vienna 13
Nanjing 12
Belo Horizonte 11
Hanoi 11
Jinan 11
Johannesburg 11
Rio de Janeiro 11
San Mateo 11
Stockholm 10
Zhengzhou 10
Milan 9
Seattle 9
Changsha 8
Jakarta 8
Rome 8
Tashkent 8
Brooklyn 7
Chennai 7
Hebei 7
Ningbo 7
Atlanta 6
Frankfurt am Main 6
Genoa 6
Montreal 6
São Bernardo do Campo 6
Taizhou 6
Tokyo 6
West Jordan 6
Amsterdam 5
Brno 5
Chicago 5
Da Nang 5
Genova 5
Haikou 5
London 5
Nova Iguaçu 5
Phoenix 5
Porto Alegre 5
Salvador 5
Aci Bonaccorsi 4
Baghdad 4
Boston 4
Brasília 4
Campinas 4
Canoas 4
Catania 4
Caxias do Sul 4
Curitiba 4
Düsseldorf 4
Fuzhou 4
General Mamerto Natividad 4
Goiânia 4
Hangzhou 4
Houston 4
Manchester 4
Mexico City 4
Mumbai 4
Nanchang 4
North Charleston 4
Nuremberg 4
Totale 3.460
Nome #
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 256
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 243
NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. 208
CD56(bright) CD16(-) killer Ig-like receptor(-) NK cells display longer telomeres and acquire features of CD56(dim) NK cells upon activation 193
Cross-dressing: an alternative mechanism for antigen presentation 180
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 176
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. 175
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 175
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cells 173
Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells 168
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 167
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 164
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 163
Human NK cells of mice with reconstituted human immune system components require pre-activation to acquire functional competence. 162
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 161
ILC in chronic inflammation, cancer and targeting with biologicals 158
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. 155
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 145
The Yin and Yang of Innate Lymphoid Cells in Cancer 144
Characterisation of innate lymphoid cell subsets infiltrating colorectal carcinoma 142
Human NK cells and NK receptors. 140
Characterization of human afferent lymph dendritic cells from seroma fluids. 136
Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS) 135
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFN-α Production 133
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells 133
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 125
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 121
BNT162b2 COVID-19 vaccination elicits the expansion of CD16+CD8+ T cells endowed with natural killer cell features 119
EPS T14 from Bacillus licheniformis Prevents Infection of Human Nasal Epithelial Cells by Respiratory Viruses 118
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 113
Identification of Natural Killer Cells in Tissues and Their Isolation 112
Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies 107
Isolation, Expansion, and Characterization of Natural Killer Cells and Their Precursors as a Tool to Study Cancer Immunosurveillance 105
Microbiota and plasticity of antigen-presenting ILC3s: impact on antitumor immune response 104
Natural Killer cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on dendritic cells 102
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-alpha production. 91
Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer 84
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade 84
Natural killer cell distribution and trafficking in human tissues. 83
Safety profile of immune checkpoint inhibitors: An analysis of the Italian spontaneous reporting system database 83
Principles of NK cell/DC crosstalk: The importance of cell dialogue for a protective immune response 77
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy 74
Natural killer cells infiltrating human non small-cell lung cancer are enriched inCD56 bright CD16(-) cells and display an impaired capability to kill tumor cells. 72
null 44
Murine models to study human NK cells in human solid tumors 37
Totale 6.040
Categoria #
all - tutte 19.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 0 30
2021/2022264 9 31 3 16 13 8 29 17 5 16 34 83
2022/2023728 67 68 39 61 49 72 8 52 273 2 15 22
2023/2024173 13 28 29 12 14 23 1 9 6 4 4 30
2024/2025913 23 4 14 51 39 29 25 233 183 62 102 148
2025/20263.089 179 180 186 207 278 580 374 427 413 165 61 39
Totale 6.040